United Therapeutics (UTHR) Tops Q3 EPS by 16c

October 27, 2016 7:59 AM EDT
Get Alerts UTHR Hot Sheet
Trade UTHR Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $3.50, $0.16 better than the analyst estimate of $3.34. Revenue for the quarter came in at $408.2 million versus the consensus estimate of $402.35 million.

For earnings history and earnings-related data on United Therapeutics (UTHR) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment